Level Biotechnology

Level Biotechnology Enterprise Value

The Enterprise Value (EV) of Level Biotechnology (3118.TWO) as of Oct 18, 2026 is 1.07 B TWD. In the previous year, Enterprise Value (EV) was 1.07 B TWD — a change of 0.00% (lower).

Enterprise Value

1.07 BTWD

YoY

0.00%

Last updated:

Enterprise Value (EV) of Level Biotechnology is 2025 1.07 B TWD. Enterprise Value (EV) of Level Biotechnology was 2024 1.07 B TWD. It decreases by 0.00% lower compared to the previous year.

The Level Biotechnology Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2018
1.07 B TWD
Jan 1, 2019
1.07 B TWD
Jan 1, 2020
701.63 M TWD
Jan 1, 2021
606.48 M TWD
Jan 1, 2022
615.31 M TWD
Jan 1, 2023
612.17 M TWD
Jan 1, 2024
1.07 B TWD
Jan 1, 2025
1.07 B TWD
The Level Biotechnology Enterprise Value history
YEAREnterprise ValueYoY
1.07 BTWD0.00%
1.07 BTWD+74.15%
612.17 MTWD-0.51%
615.31 MTWD+1.46%
606.48 MTWD-13.56%
701.63 MTWD-34.19%
1.07 BTWD0.00%
1.07 BTWD0.00%
1.07 BTWD+46.44%
727.98 MTWD+0.58%
723.78 MTWD-3.36%
748.92 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Level Biotechnology Stock analysis

What does Level Biotechnology do? Level Biotechnology Inc is a company based in Taipei, Taiwan, operating within the Health Care sector. It went public on September 10, 2004, with its ticker symbol 3118.TWO and ISIN TW0003118006. The company provides biotechnological services, focusing on products such as cell culture series, immune protein series, gene nucleic acid and molecular biology series, and instrument series. Additionally, Level Biotechnology offers preclinical testing services, including genetic toxicity testing, general toxicology testing, reproductive toxicology testing, pharmacokinetic testing, and biocompatibility testing. The company's website is https://www.level.com.tw/index_tw.php. Level Biotechnology operates primarily in the domestic market, serving clients within Taiwan. It is headquartered in Taipei, New Taipei, as stated in the provided information. The company's services and products are designed to support research and development in the biotechnology and health care fields. No additional details about founding year, key personnel, acquisitions, or specific financial figures are provided in the given data. The company's activities are centered around delivering specialized biotechnological solutions to its market. Level Biotechnology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Level Biotechnology stock

Enterprise Value (EV) of Level Biotechnology is 1.07 B TWD in 2025.

Enterprise Value (EV) of Level Biotechnology changed from 1.07 B TWD to 1.07 B TWD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Level Biotechnology since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s TWD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' TWD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Level Biotechnology with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Level Biotechnology

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Level Biotechnology